Amid the increase in coronavirus cases in India, Dr. Randeep Guleria, director of AIIMS and member of the national task force on the management of COVID-19, has said that ordinary Indians will have to wait until 2022 to receive the vaccine. COVID-19.
Dr Guleria stated that it will take “more than a year” for a genuine coronavirus vaccine to reach the Indian market.
“In our country the population is large; we need time to see how the vaccine can be bought in the market as a flu vaccine and take it. That will really be the ideal situation. So it could be late 2021 to early 2022, “Dr. Guleria said in an exclusive interview with CNN-News18.
Speaking about the sudden increase in the number of COVID-19 cases in Delhi, Dr. Guleria said that there are several factors responsible for this increase in coronavirus cases in the national capital. “One is the weather. We know that respiratory viruses increase in the winter months; We have seen a drop in temperature in Delhi. The virus is more likely to survive outdoors, and people tend to huddle indoors during winters. The third factor is air pollution, which is also contributing to the increase, ”he said.
Meanwhile, the number of COVID-19 cases in India surpassed 85 lakh, while the number of people who have recovered from the deadly viral disease increased to 78,68,968, bringing the national recovery rate to 92. , 49 percent.
According to data from the Union Ministry of Health updated on Sunday, the total number of coronavirus cases rose to 85,07,754 with 45,674 infections reported in one day. The total death toll reached 1.26,121 with 559 new deaths in the last 24 hours.
The fatality rate stands at 1.48%. The number of active COVID-19 cases remained below 6 lakh for the 10th consecutive day.
On live Tv
There are 5,12665 active cases of coronavirus infection in the country to date, representing 6.03 percent of the total number of cases, according to the data.
.
